Secondary Adrenal Insufficiency Due to the Co-Administration of Ritonavir and Inhaled Fluticasone Propionate : Case report
Ritonavir is a powerful inhibitor of the cytochrome P450 3A4 (CYP3A4) isoenzyme. It is used as a pharmaceutical enhancer in the management of HIV-positive patients. However, when co-administered with other drugs that are metabolised via the CYP3A4 pathway, ritonavir can potentially cause serious dru...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sultan Qaboos University
2017-08-01
|
Series: | Sultan Qaboos University Medical Journal |
Subjects: | |
Online Access: | https://journals.squ.edu.om/index.php/squmj/article/view/2234 |